Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Barinthus Biotherapeutics (BRNS) Other Non Operating Income (2020 - 2025)

Barinthus Biotherapeutics' Other Non Operating Income history spans 6 years, with the latest figure at -$104000.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income fell 216.85% year-over-year to -$104000.0; the TTM value through Dec 2025 reached $16000.0, down 88.15%, while the annual FY2025 figure was $16000.0, 88.15% down from the prior year.
  • Other Non Operating Income reached -$104000.0 in Q4 2025 per BRNS's latest filing, up from -$275000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $13.8 million in Q1 2022 to a low of -$275000.0 in Q3 2025.
  • Average Other Non Operating Income over 5 years is $1.7 million, with a median of $82000.0 recorded in 2024.
  • Peak YoY movement for Other Non Operating Income: soared 199800.0% in 2021, then plummeted 1157.69% in 2025.
  • A 5-year view of Other Non Operating Income shows it stood at $6.0 million in 2021, then plummeted by 91.4% to $516000.0 in 2022, then soared by 50.0% to $774000.0 in 2023, then crashed by 88.5% to $89000.0 in 2024, then plummeted by 216.85% to -$104000.0 in 2025.
  • Per Business Quant, the three most recent readings for BRNS's Other Non Operating Income are -$104000.0 (Q4 2025), -$275000.0 (Q3 2025), and $320000.0 (Q2 2025).